U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07849543) titled 'Contrast-enhanced Ultrasound Evaluation of Indeterminate Ovarian Lesions: Prospective Multicenter Study' on Sept. 24.

Brief Summary: The goal of this clinical trial is to learn how well contrast-enhanced ultrasound (CEUS) can diagnose ovarian cancer in patients with indeterminate or suspicious ovarian/adnexal lesions identified on routine ultrasound or MRI.

The main questions it aims to answer are:

How accurately can qualitative CEUS imaging features distinguish malignant from benign ovarian/adnexal lesions?

How consistent are the CEUS assessments among different readers, and can combining CEUS findings with MRI and clinical infor...